<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05045885</url>
  </required_header>
  <id_info>
    <org_study_id>MRC-01-20-1196</org_study_id>
    <nct_id>NCT05045885</nct_id>
  </id_info>
  <brief_title>Safety and Feasibility of Percutaneous Dilatational Tracheostomy in Patients With Severe COVID-19 Supported by ECMO</brief_title>
  <official_title>Safety and Feasibility of Percutaneous Dilatational Tracheostomy in Patients With Severe COVID-19 Disease Supported by Extracorporeal Membrane Oxygenation.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hamad Medical Corporation</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Hamad Medical Corporation</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      COVID-19 pandemic has presented the global health care systems with unprecedented and&#xD;
      unexpected challenges. The clinical spectrum of COVID-19 disease varies from mild, at times&#xD;
      asymptomatic, to severe life-threatening multiple organ dysfunction and shock. The latter&#xD;
      group, albeit represent less than 10% of all SARS-CoV-2 infections will require ICU&#xD;
      admission, multi-modal organ support including Extracorporeal Membrane Oxygenation (ECMO) for&#xD;
      severe refractory cardiac and/or pulmonary failure.&#xD;
&#xD;
      Prolonged mechanical ventilation is a typical indication for tracheostomy. Percutaneous&#xD;
      tracheostomy at the bedside has several advantages over surgical tracheostomy. However, with&#xD;
      the emerging pandemic, there is a lack of literature regarding the safety of percutaneous&#xD;
      bedside tracheostomy for patients with COVID-19 supported by ECMO.&#xD;
&#xD;
      Our study aims to describe the safety of bedside percutaneous dilatational tracheostomy of&#xD;
      confirmed COVID-19 positive patients supported on ECMO.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      At the time of writing, more than 50 million confirmed cases of COVID-19 have been reported&#xD;
      worldwide with over one million reported deaths1 Data about ICU mortality is variable and may&#xD;
      be affected by the infrastructure of the health care system in each country, however, the&#xD;
      estimated mortality rate in COVID-19 patients who need ICU is 25.7%-35.7%2.&#xD;
&#xD;
      The World Health Organization (WHO) suggests ECMO for COVID-19 patients with severe ARDS not&#xD;
      responding to conventional treatment. However, Extracorporeal Life Support Organization&#xD;
      (ESLSO) guidance recommends a balance of resource utilization, allocation, and appropriate&#xD;
      case selection3.&#xD;
&#xD;
      According to ELSO Registry; 3048 COVID-19 cases have been supported on ECMO. Interestingly&#xD;
      discharge alive rate was reported to be over 60%4.&#xD;
&#xD;
      Tracheostomy can be performed with two different techniques. Open 'surgical' tracheostomy&#xD;
      (OT) and percutaneous dilatational tracheostomy (PDT). The later was favored during the SARS&#xD;
      outbreak (SARS-CoV-1). However, the literature is not clear yet about the preferable and&#xD;
      safest technique during Covid-19 disease SARS-CoV-2 as both procedures could be&#xD;
      aerosol-generating procedures (AGP)5,6.&#xD;
&#xD;
      SARS-CoV-2 is highly contagious and can spread via aerosol, contact, and droplet. This poses&#xD;
      a significant risk to health care workers (HCW) and in particular during airway interventions&#xD;
      and procedures.&#xD;
&#xD;
      The optimal time to perform tracheostomy in COVID-19 patients remains controversial.&#xD;
      Recommendations are different whether early or late tracheostomy is the preferred one,&#xD;
      however, the American Academy of Otolaryngology-Head and Neck surgery recommend the procedure&#xD;
      to take a place 2-3 weeks after intubation5,6.&#xD;
&#xD;
      Generally speaking, tracheostomy has many advantages in critically ill patients such as&#xD;
      reducing the days of mechanical ventilation, reduce ICU admission, reduce nosocomial&#xD;
      pneumonia in special groups7,8.&#xD;
&#xD;
      Tracheostomy carries the second-highest risk of transmission of infection to staff after&#xD;
      endotracheal intubation. PDT in patients supported on ECMO is not without risks. Bleeding is&#xD;
      a major concern and has been reported at 40%9-11. Other reported procedural complications are&#xD;
      mechanical and ECMO-circuit dysfunction9-12.&#xD;
&#xD;
      The literature search revealed one case series from the UK13 of PDT in the same patient&#xD;
      population as our study. However, the report focuses on the description of the procedure&#xD;
      rather than the safety aspect. To my knowledge, this is the first study to look in-depth into&#xD;
      staff and patient safety of PDT in COVID-19 positive patients on ECMO support.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">March 1, 2020</start_date>
  <completion_date type="Actual">December 1, 2020</completion_date>
  <primary_completion_date type="Actual">November 30, 2020</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Other</time_perspective>
  </study_design_info>
  <target_duration>1 Year</target_duration>
  <primary_outcome>
    <measure>External or endotracheal bleeding (mild, moderate, sever)</measure>
    <time_frame>24 hours Post procedure</time_frame>
    <description>Mild: Minimal external or endotracheal bleeding with minimal or no drop-in haemoglobin and no surgical intervention.&#xD;
Moderate: Obvious external or endotracheal bleed. A drop-in haemoglobin of less than one gram/dL or transfusion of one unit of red blood cells.&#xD;
Severe bleeding: a drop of two grams or more in haemoglobin/dL and/or transfusion of two or more red cell packs or other blood products, disseminated intravascular coagulopathy (DIC) or need for surgical intervention</description>
  </primary_outcome>
  <enrollment type="Actual">32</enrollment>
  <condition>COVID-19 Pneumonia</condition>
  <condition>Extracorporeal Membrane Oxygenation Complication</condition>
  <condition>Tracheostomy Complication</condition>
  <condition>Respiratory Failure</condition>
  <eligibility>
    <study_pop>
      <textblock>
        The COVID and non-COVID patients on VV ECMO who underwent percutaneous dilatational&#xD;
        tracheostomy (PDT).&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  over 18-years old.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  less than 18 years old,&#xD;
&#xD;
          -  Pregnancy&#xD;
&#xD;
          -  VA-ECMO&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ahmed Labib</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hamad Medical Corporation - HMC</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Hamad Medical Corporation</name>
      <address>
        <city>Doha</city>
        <zip>3050</zip>
        <country>Qatar</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Qatar</country>
  </location_countries>
  <reference>
    <citation>WHO Director-General's opening remarks at the media briefing on COVID-19: 11 March 2020. Published March 11, 2020</citation>
  </reference>
  <reference>
    <citation>COVID Live Update: 189,294,523 Cases and 4,076,726 Deaths from the Coronavirus - Worldometer. Worldometers.info. https://www.worldometers.info/coronavirus/. Published 2021. Accessed July 15, 2021.</citation>
  </reference>
  <reference>
    <citation>Extracorporeal Life Support Organization - ECMO and ECLS. Elso.org. https://www.elso.org/COVID19.aspx. Published 2021. Accessed June 9, 2021.</citation>
  </reference>
  <reference>
    <citation>Tracheotomy Recommendations During the COVID-19 Pandemic - American Academy of Otolaryngology-Head and Neck Surgery (AAO-HNS). American Academy of Otolaryngology-Head and Neck Surgery (AAO-HNS). https://www.entnet.org/resource/tracheotomy-recommendations-during-the-covid-19-pandemic-2/. Published 2021. Accessed June 9, 2021.</citation>
  </reference>
  <results_reference>
    <citation>Grasselli G, Pesenti A, Cecconi M. Critical Care Utilization for the COVID-19 Outbreak in Lombardy, Italy: Early Experience and Forecast During an Emergency Response. JAMA. 2020 Apr 28;323(16):1545-1546. doi: 10.1001/jama.2020.4031.</citation>
    <PMID>32167538</PMID>
  </results_reference>
  <results_reference>
    <citation>Grasselli G, Zangrillo A, Zanella A, Antonelli M, Cabrini L, Castelli A, Cereda D, Coluccello A, Foti G, Fumagalli R, Iotti G, Latronico N, Lorini L, Merler S, Natalini G, Piatti A, Ranieri MV, Scandroglio AM, Storti E, Cecconi M, Pesenti A; COVID-19 Lombardy ICU Network. Baseline Characteristics and Outcomes of 1591 Patients Infected With SARS-CoV-2 Admitted to ICUs of the Lombardy Region, Italy. JAMA. 2020 Apr 28;323(16):1574-1581. doi: 10.1001/jama.2020.5394. Erratum in: JAMA. 2021 May 25;325(20):2120.</citation>
    <PMID>32250385</PMID>
  </results_reference>
  <results_reference>
    <citation>Auld SC, Caridi-Scheible M, Blum JM, Robichaux C, Kraft C, Jacob JT, Jabaley CS, Carpenter D, Kaplow R, Hernandez-Romieu AC, Adelman MW, Martin GS, Coopersmith CM, Murphy DJ; and the Emory COVID-19 Quality and Clinical Research Collaborative. ICU and Ventilator Mortality Among Critically Ill Adults With Coronavirus Disease 2019. Crit Care Med. 2020 Sep;48(9):e799-e804. doi: 10.1097/CCM.0000000000004457.</citation>
    <PMID>32452888</PMID>
  </results_reference>
  <results_reference>
    <citation>Shekar K, Badulak J, Peek G, Boeken U, Dalton HJ, Arora L, Zakhary B, Ramanathan K, Starr J, Akkanti B, Antonini MV, Ogino MT, Raman L, Barret N, Brodie D, Combes A, Lorusso R, MacLaren G, Müller T, Paden M, Pellegrino V; ELSO Guideline Working Group. Extracorporeal Life Support Organization Coronavirus Disease 2019 Interim Guidelines: A Consensus Document from an International Group of Interdisciplinary Extracorporeal Membrane Oxygenation Providers. ASAIO J. 2020 Jul;66(7):707-721. doi: 10.1097/MAT.0000000000001193.</citation>
    <PMID>32604322</PMID>
  </results_reference>
  <results_reference>
    <citation>Nieszkowska A, Combes A, Luyt CE, Ksibi H, Trouillet JL, Gibert C, Chastre J. Impact of tracheotomy on sedative administration, sedation level, and comfort of mechanically ventilated intensive care unit patients. Crit Care Med. 2005 Nov;33(11):2527-33.</citation>
    <PMID>16276177</PMID>
  </results_reference>
  <results_reference>
    <citation>Dempsey GA, Grant CA, Jones TM. Percutaneous tracheostomy: a 6 yr prospective evaluation of the single tapered dilator technique. Br J Anaesth. 2010 Dec;105(6):782-8. doi: 10.1093/bja/aeq238. Epub 2010 Sep 2.</citation>
    <PMID>20813838</PMID>
  </results_reference>
  <results_reference>
    <citation>Beiderlinden M, Eikermann M, Lehmann N, Adamzik M, Peters J. Risk factors associated with bleeding during and after percutaneous dilational tracheostomy. Anaesthesia. 2007 Apr;62(4):342-6.</citation>
    <PMID>17381569</PMID>
  </results_reference>
  <results_reference>
    <citation>Tang S, Mao Y, Jones RM, Tan Q, Ji JS, Li N, Shen J, Lv Y, Pan L, Ding P, Wang X, Wang Y, MacIntyre CR, Shi X. Aerosol transmission of SARS-CoV-2? Evidence, prevention and control. Environ Int. 2020 Nov;144:106039. doi: 10.1016/j.envint.2020.106039. Epub 2020 Aug 7. Review.</citation>
    <PMID>32822927</PMID>
  </results_reference>
  <results_reference>
    <citation>Weissman DN, de Perio MA, Radonovich LJ Jr. COVID-19 and Risks Posed to Personnel During Endotracheal Intubation. JAMA. 2020 May 26;323(20):2027-2028. doi: 10.1001/jama.2020.6627.</citation>
    <PMID>32338710</PMID>
  </results_reference>
  <results_reference>
    <citation>Chorath K, Hoang A, Rajasekaran K, Moreira A. Association of Early vs Late Tracheostomy Placement With Pneumonia and Ventilator Days in Critically Ill Patients: A Meta-analysis. JAMA Otolaryngol Head Neck Surg. 2021 May 1;147(5):450-459. doi: 10.1001/jamaoto.2021.0025.</citation>
    <PMID>33704354</PMID>
  </results_reference>
  <results_reference>
    <citation>Zangrillo A, Landoni G, Biondi-Zoccai G, Greco M, Greco T, Frati G, Patroniti N, Antonelli M, Pesenti A, Pappalardo F. A meta-analysis of complications and mortality of extracorporeal membrane oxygenation. Crit Care Resusc. 2013 Sep;15(3):172-8. Review.</citation>
    <PMID>23944202</PMID>
  </results_reference>
  <results_reference>
    <citation>Braune S, Kienast S, Hadem J, Wiesner O, Wichmann D, Nierhaus A, Simon M, Welte T, Kluge S. Safety of percutaneous dilatational tracheostomy in patients on extracorporeal lung support. Intensive Care Med. 2013 Oct;39(10):1792-9. doi: 10.1007/s00134-013-3023-8. Epub 2013 Jul 27.</citation>
    <PMID>23892417</PMID>
  </results_reference>
  <results_reference>
    <citation>Kruit N, Valchanov K, Blaudszun G, Fowles JA, Vuylsteke A. Bleeding Complications Associated With Percutaneous Tracheostomy Insertion in Patients Supported With Venovenous Extracorporeal Membrane Oxygen Support: A 10-Year Institutional Experience. J Cardiothorac Vasc Anesth. 2018 Jun;32(3):1162-1166. doi: 10.1053/j.jvca.2017.08.010. Epub 2017 Aug 3.</citation>
    <PMID>29129346</PMID>
  </results_reference>
  <results_reference>
    <citation>Salna M, Tipograf Y, Liou P, Chicotka S, Biscotti M 3rd, Agerstrand C, Abrams D, Brodie D, Bacchetta M. Tracheostomy Is Safe During Extracorporeal Membrane Oxygenation Support. ASAIO J. 2020 Jun;66(6):652-656. doi: 10.1097/MAT.0000000000001059.</citation>
    <PMID>31425269</PMID>
  </results_reference>
  <results_reference>
    <citation>Dimopoulos S, Joyce H, Camporota L, Glover G, Ioannou N, Langrish CJ, Retter A, Meadows CIS, Barrett NA, Tricklebank S. Safety of Percutaneous Dilatational Tracheostomy During Veno-Venous Extracorporeal Membrane Oxygenation Support in Adults With Severe Respiratory Failure. Crit Care Med. 2019 Feb;47(2):e81-e88. doi: 10.1097/CCM.0000000000003515.</citation>
    <PMID>30431492</PMID>
  </results_reference>
  <results_reference>
    <citation>Valchanov K, Salaunkey K, Parmar J. Percutaneous Dilatational Tracheostomy in Coronavirus Disease 2019 Extracorporeal Membrane Oxygenation Patients: A Case Series. J Cardiothorac Vasc Anesth. 2021 Jan;35(1):348-350. doi: 10.1053/j.jvca.2020.06.024. Epub 2020 Jun 12.</citation>
    <PMID>32620486</PMID>
  </results_reference>
  <results_reference>
    <citation>Lamb CR, Desai NR, Angel L, Chaddha U, Sachdeva A, Sethi S, Bencheqroun H, Mehta H, Akulian J, Argento AC, Diaz-Mendoza J, Musani A, Murgu S. Use of Tracheostomy During the COVID-19 Pandemic: American College of Chest Physicians/American Association for Bronchology and Interventional Pulmonology/Association of Interventional Pulmonology Program Directors Expert Panel Report. Chest. 2020 Oct;158(4):1499-1514. doi: 10.1016/j.chest.2020.05.571. Epub 2020 Jun 6.</citation>
    <PMID>32512006</PMID>
  </results_reference>
  <results_reference>
    <citation>El Bouzidi K, Pirani T, Rosadas C, Ijaz S, Pearn M, Chaudhry S, Patel S, Sureda-Vives M, Fernandez N, Khan M, Cherepanov P, McClure MO, Tedder RS, Zuckerman M; COVID-STOICS (Serological Testing Of Intensive Care Staff). Severe Acute Respiratory Syndrome Coronavirus-2 Infections in Critical Care Staff: Beware the Risks Beyond the Bedside. Crit Care Med. 2021 Mar 1;49(3):428-436. doi: 10.1097/CCM.0000000000004878.</citation>
    <PMID>33512941</PMID>
  </results_reference>
  <verification_date>August 2021</verification_date>
  <study_first_submitted>September 14, 2021</study_first_submitted>
  <study_first_submitted_qc>September 14, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">September 16, 2021</study_first_posted>
  <last_update_submitted>September 14, 2021</last_update_submitted>
  <last_update_submitted_qc>September 14, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">September 16, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>COVID-19</mesh_term>
    <mesh_term>Respiratory Insufficiency</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>After approval of Hospital IRB</ipd_description>
    <ipd_info_type>Study Protocol</ipd_info_type>
    <ipd_time_frame>After finishing the study</ipd_time_frame>
    <ipd_access_criteria>Website</ipd_access_criteria>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

